NCT01501578

Brief Summary

This study is an observational and retrospective study of patients with pulmonary fibrosis associated or not with telomerase mutation. The purpose of this study is to describe in detail the cases with telomerase mutation in terms of features on CT scan, respiratory function and evolution, in comparison to control subjects with idiopathic pulmonary fibrosis and no telomerase mutation identified or family history.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

December 13, 2011

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 29, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
3.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

February 20, 2018

Status Verified

February 1, 2018

Enrollment Period

6 months

First QC Date

December 13, 2011

Last Update Submit

February 19, 2018

Conditions

Keywords

Pulmonary fibrosisTelomerase mutation

Outcome Measures

Primary Outcomes (1)

  • Description of imaging pattern

    Description of imaging pattern on representative CT scan at diagnosis.

    at baseline only

Secondary Outcomes (2)

  • Pathology of the lung

    at baseline only

  • Pulmonary function tests

    from diagnosis to last follow-up, for an average of one year

Study Arms (2)

telomerase mutation

Patients with interstitial lung disease and telomerase mutation

control

Patients with idiopathic pulmonary fibrosis and without telomerase mutation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with pulmonary fibrosis with and without telomerase mutation

You may qualify if:

  • Diffuse interstitial lung disease on CT scan
  • Telomerase mutation analysis

You may not qualify if:

  • Presence of connective tissue disease, or pneumoconiosis or drug induced lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Louis Pradel Hospital (Bâtiment A4)

Lyon, 69677, France

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

one blood sample is collected for genetic analysis of telomerase mutation

MeSH Terms

Conditions

Pulmonary Fibrosis

Condition Hierarchy (Ancestors)

Lung Diseases, InterstitialLung DiseasesRespiratory Tract DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • vincent Cottin, MD

    Hospices civils de Lyon / University Lyon I

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 13, 2011

First Posted

December 29, 2011

Study Start

December 1, 2011

Primary Completion

June 1, 2012

Study Completion

December 1, 2015

Last Updated

February 20, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will share

Under analysis, publication in preparation

Locations